46 results
424B3
CHRO
Chromocell Therapeutics Corp.
15 May 24
Prospectus supplement
4:21pm
a pill when patients are experiencing nausea. Under the terms of the Benuvia License Agreement, Benuvia will be responsible for the manufacturing
424B3
CHRO
Chromocell Therapeutics Corp.
15 May 24
Prospectus supplement
4:15pm
a pill when patients are experiencing nausea. Under the terms of the Benuvia License Agreement, Benuvia will be responsible for the manufacturing
10-Q
2024 Q1
EX-31.1
CHRO
Chromocell Therapeutics Corp.
15 May 24
Quarterly report
4:06pm
officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e
10-Q
2024 Q1
CHRO
Chromocell Therapeutics Corp.
15 May 24
Quarterly report
4:06pm
License Agreement, Benuvia will be responsible for the manufacturing and supply of the Spray Formulations, but we will have exclusive, worldwide rights
424B3
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Prospectus supplement
5:49pm
bioavailability and a more rapid onset of action which may be responsible for better results in resolving migraines as well as better results in patients reporting … swallowing a pill when patients are experiencing nausea. Under the terms of the Benuvia License Agreement, Benuvia will be responsible for the manufacturing
424B3
42tf1wsa bwo5
16 Apr 24
Prospectus supplement
5:45pm
10-K
EX-31.1
xcgmfcier0neo1 96de
16 Apr 24
Annual report
4:48pm
10-K
EX-31.2
33o7mite myuaucz
16 Apr 24
Annual report
4:48pm
10-K
EX-19.1
o61h3oew1k30
16 Apr 24
Annual report
4:48pm
10-K
3c432 3zqrqxvajjo2
16 Apr 24
Annual report
4:48pm
8-K
EX-1.1
cl1li3t11pffdzre2
22 Feb 24
Chromocell Therapeutics Announces Pricing of Upsized $6.6 Initial Public Offering
4:05pm
8-K
EX-4.1
xazupq0pn5
22 Feb 24
Chromocell Therapeutics Announces Pricing of Upsized $6.6 Initial Public Offering
4:05pm
424B4
zvnx xzzo5
20 Feb 24
Prospectus supplement with pricing info
5:30pm
424B4
rqqt9440s1gvgm v3mwf
20 Feb 24
Prospectus supplement with pricing info
5:28pm